ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
1 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
384
|
176K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
7 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
384
|
176K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
384
|
176K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
13 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
384
|
176K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
7 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
384
|
176K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
176K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Wilba32
|
777 |
345K |
10 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
777
|
345K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
10 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
176K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
176K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
4 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
176K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Wilba32
|
384 |
176K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
176K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.8K |
2.9M |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
5 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
30 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
5 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
12 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
2 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
18K |
7.0M |
15 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
18K
|
7.0M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
interleukin-11
|
|
Wilba32
|
7 |
3.5K |
17 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
7
|
3.5K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
5 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
4 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
28 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.8K |
2.9M |
13 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
14 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
9 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.8K |
2.9M |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
5.8K
|
2.9M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
Wilba32
|
131 |
57K |
3 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
131
|
57K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
15 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
23 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
4 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
265
|
107K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wilba32
|
67 |
25K |
13 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
25K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
11 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
18K |
7.0M |
15 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
18K
|
7.0M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
2 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
107K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
107K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
4 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
107K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
7 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
265
|
107K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
11 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
265
|
107K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
33 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
107K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
18K |
7.0M |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
18K
|
7.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
7 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
107K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
107K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Wilba32
|
265 |
107K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
107K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
11K |
3.5M |
4 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
11K
|
3.5M
|
4
|
|